Ireland joins international collaboration on drug pricing and supply
Two weeks ago the Irish Minister for Health has signed an Agreement to join the BeNeLuxA initiative on pharmaceutical policy.
In 2015 the BeNeLuxA cooperation was initiated by the Netherlands and Belgium. Since then, Luxembourg joined the cooperation followed by Austria. The BeNeLuxA initiative aims for sustainable access to, and appropriate use of, medicines in the participating countries.
By working together, the participating countries strive to increase patients’ access to high quality and affordable treatments. In order to achieve this goal, the initiative focuses on four domains of cooperation:
- Horizon Scanning: participating countries work together to find out which innovative (often extremely expensive) medicines will become available in the near future.
- Information sharing and policy exchange: Member States exchange information on their medicine policies.
- Health Technology Assessment: the goal is to perform several joint Health Technology Assessment procedures per year.
- Pricing and Reimbursement: participants collaborate through sharing information and experiences on specific pharmaceuticals that are part of past, current or expected reimbursement procedures.
BeneLuxA is a first collaborative step towards more balance in the pharmaceutical market. Membership of the Initiative is open to EU Member States and other interested countries.
Should you have queries, please contact Aurélie Mingels or your trusted Loyens & Loeff adviser.